Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily (Q28271806)

British Journal of Haematology

Europe PubMed Central

title

Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily (English)

0 references

2

James P Allison

0 references

author name string

Karl S Peggs

series ordinal

1

0 references

language of work or name

English

0 references

publication date

September 2005

0 references

published in

0 references

volume

130

0 references

issue

6

0 references

page(s)

809-24

0 references

cites work

Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

ICOS co-stimulatory receptor is essential for T-cell activation and function

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

21 April 2017

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

ICOS is critical for CD40-mediated antibody class switching

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

T-cell co-stimulation through B7RP-1 and ICOS

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

B7x: a widely expressed B7 family member that inhibits T cell activation

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2005.05627.X

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

CD28-mediated co-stimulation: a quantitative support for TCR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

CD4(+) CD25(+) regulatory T cell selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

CD4+CD25+ T cells as immunoregulatory T cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Induction of cytotoxic T lymphocyte antigen 4 (CTLA-4) restricts clonal expansion of helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Modulation of tryptophan catabolism by regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Quantitative analysis of the T cell repertoire selected by a single peptide-major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Selecting and maintaining a diverse T-cell repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Quantitative determination of TCR cross-reactivity using peptide libraries and protein databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

The repertoire of T cells shaped by a single MHC/peptide ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Selection of antigen-specific T cells by a single IEk peptide combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Structural analysis of CTLA-4 function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Molecular interactions mediating T cell antigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

B7h is required for T cell activation, differentiation, and effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

B7S1, a novel B7 family member that negatively regulates T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Interaction Between ICOS-B7RP1 and B7-CD28 Costimulatory Pathways in Alloimmune Responses In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

ICOS deficiency in patients with common variable immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

The inducible costimulator plays the major costimulatory role in humoral immune responses in the absence of CD28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Antagonistic roles for CTLA-4 and the mammalian target of rapamycin in the regulation of clonal anergy: enhanced cell cycle progression promotes recall antigen responsiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Structural and functional analysis of the costimulatory receptor programmed death-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Transplantation of anergic histoincompatible bone marrow allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05627.X

Treatment of murine lupus with CTLA4Ig

21 January 2018

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

T cell activation determined by T cell receptor number and tunable thresholds.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

A very high level of crossreactivity is an essential feature of the T-cell receptor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

CD4+CD25high regulatory cells in human peripheral blood

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2141.2005.05627.X

Identifiers

DOI

10.1111/J.1365-2141.2005.05627.X

0 references

Fatcat ID

release_q6iepocdzjal5jc5lz7xfdr63u

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q6iepocdzjal5jc5lz7xfdr63u